flow statement The cash flow statement of six months as of 30 June 2017 and 30 June 2016 decreases 7.63% or 77.12 million THB from the same period i.e. from 1,010.30 million THB to 933.18 million THB as
respectively. Cash flow statement The cash flow statement of nine months as of 30 September 2017 and 30 September 2016 decreases 12.97% or 93.07 million THB from the same period i.e. from 717.33 million THB to
: 1 as of 31st December 2016 and 2017 respectively. Cash flow statement The cash flow statement as of 31st December 2017 and 2016 decreases 234.75 million THB or 39.71% from the previous year i.e. from
$819 million, up 33% YoY Earnings Per Share of THB 4.61, +16% YoY Operating Cash Flow of $1.0 billion 2019 Earnings Guidance reaffirmed Indorama Ventures 2018 MD&A 2 2018 Summary Financials Table 1
02-634-0135 www.interpharma.co.th 4. MP Financial Statement Balance Sheet (Unit : Baht) 2017 Audited Statement 2018 Audited Statement 2019 Audited Statement Assets Current Assets Cash and cash
+3.3% from retained earnings. Net debt to EBITDA (excluding lease liabilities and license payable) was 0.7x slightly decline compared to 4Q19. Cash flow (Post TFRS 9&16) In 1H20, Cash flow from operating
decrease in retained earnings. Cash flow For 9M21, cash flow from operation (after tax) was Bt64,699mn increasing +9.2%YoY on the back of EBITDA expansion. The investment to expand 5G/4G and fixed broadband
impact, enterprise business and others grew 4.6%. 4Q23 & FY23 MD&A Advanced Info Service Plc. 4 Cash flow In FY23, cash flow from operation (after tax) reported at Bt87,641mn, increasing 7.7% compared to
asset as of ending quarter declined -5.4% from the end of 2023 to Bt429,869mn. Current assets was at Bt40,653mn, decreasing -3.8% mainly from lower cash balance due to dividends paid. Total non-current
the current circumstance, therefore has since adjusted the marketing strategy of the Company and the Subsidiary Company to focus tourism in Thailand in order to be able to reopen Phuket Fantasea on the